Sign Out
Pregnancy: Reproduction studies in animals (mice and rats) with oral and parenteral administrations have shown no teratogenic effects. Premature rupture of the foetal membrane (pPROM) was reported that prophylactic treatment with amoxicillin plus clavulanic acid may be associated with an increased risk of necrotizing enterocolitis in neonates. Avoid using in pregnancy, (especially during the first trimester - for Camoxtin), unless considered essential by the physician.
Lactation: This medicine may be administered during the period of lactation. With the exception of the risk of sensitization, associated with the excretion of trace quantities in the breast milk, there are no detrimental effects for the infant.
Continue with Google